Abstract
The Public Health Laboratory Service receives antibiotic susceptibility data for bacteria from bloodstream infections from most hospitals in England and Wales. These data were used to ascertain resistance trends to ciprofloxacin from 1990 through 1999 for the most prevalent gram-negative agents: Escherichia coli, Klebsiella spp., Enterobacter spp., and Proteus mirabilis. Significant increases in resistance were observed for all four species groups. For E. coli, ciprofloxacin resistance rose from 0.8% in 1990 to 3.7% in 1999 and became widely scattered among reporting hospitals. The prevalence of resistance in Klebsiella spp. rose from 3.5% in 1990, to 9.5% in 1996 and 7.1% in 1999, while that in Enterobacter spp. rose from 2.1% in 1990 to 10.5% in 1996 and 10.9% in 1999. For both Klebsiella and Enterobacter spp., most resistance was localized in a few centers. Resistance was infrequent and scattered in P. mirabilis, but reached a prevalence of 3.3% in 1999.
MeSH Terms
Bacteremia/drug therapy,microbiology
Ciprofloxacin/pharmacology,therapeutic use
Drug Resistance, Bacterial
Drug Utilization
England/epidemiology
Enterobacteriaceae/drug effects,physiology
Enterobacteriaceae Infections/drug therapy,microbiology
Fluoroquinolones/pharmacology,therapeutic use
Humans
Practice Patterns, Physicians'
Wales/epidemiology
Chemicals
Fluoroquinolones
Ciprofloxacin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Livermore David M
Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK. DLivermore@phls.nhs.uk
James Dorothy
Reacher Mark
Graham Catriona
Nichols Thomas
Stephens Peter
Johnson Alan P
George Robert C
References (17)
17 references, click to expand
-
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.
Antimicrob Agents Chemother. 1994 Apr;38(4):681-7
PMID: 8031031
-
Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.
Antimicrob Agents Chemother. 1996 Oct;40(10):2380-6
PMID: 8891148
-
Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea.
Clin Infect Dis. 1997 Dec;25(6):1385-91
PMID: 9431383
-
Emerging bacterial drug resistance in hospital practice.
Indian J Med Sci. 1997 Aug;51(8):275-80
PMID: 9491681
-
Quinolone resistance from a transferable plasmid.
Lancet. 1998 Mar 14;351(9105):797-9
PMID: 9519952
-
Antibiotic resistance in Escherichia coli isolated from blood and cerebrospinal fluid: a 6-year study of isolates from patients in England and Wales.
Int J Antimicrob Agents. 1997 Jan;9(3):201-5
PMID: 9552717
-
Multiresistant bacteria as a hospital epidemic problem.
Ann Med. 1998 Apr;30(2):176-85
PMID: 9667796
-
Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis.
Infection. 1998 Nov-Dec;26(6):379-84
PMID: 9861564
-
Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria.
Clin Infect Dis. 1999 Sep;29(3):490-4
PMID: 10530434
-
Emergence and dissemination of quinolone-resistant Escherichia coli in the community.
Antimicrob Agents Chemother. 1999 Nov;43(11):2736-41
PMID: 10543756
-
Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin.
J Med Chem. 1999 Dec 2;42(24):4928-31
PMID: 10585202
-
Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis.
BMJ. 2000 Jan 22;320(7229):213-6
PMID: 10642227
-
Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing.
J Antimicrob Chemother. 2000 Feb;45(2):205-11
PMID: 10660502
-
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Eur J Clin Microbiol. 1983 Apr;2(2):111-5
PMID: 6222896
-
The mode of action of 4-quinolones and possible mechanisms of resistance.
J Antimicrob Chemother. 1986 Nov;18 Suppl D:21-9
PMID: 3542946
-
A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy.
J Antimicrob Chemother. 1991 Jun;27 Suppl D:1-50
PMID: 1874686
-
Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.
Drugs. 1993;45 Suppl 3:73-80
PMID: 7689455